Press release

UCLB has entered into an exclusive licence agreement with BioKier, Inc. for the proprietary colon delivery technology PhloralTM developed by researchers at the UCL School of Pharmacy.

UCL is partnering with Novo Nordisk and the Steno Diabetes Center – a world leading institution in diabetes care and prevention – to launch the Cities Changing Diabetes initiative, an ambitious new partnership programme to fight urban diabetes.

Since the end of last year, Switzerland has boasted the most powerful supercomputer in Europe: “Piz Daint”. As of today, it is officially cleared for research. For the approval, “early science” has already been conducted successfully on “Piz Daint” over the last few weeks.

Chalmers Students for Sustainability (CSS) is proud to announce the start of their annual ”The Reflecting Engineer” lunch lectures. It started on March 25 with professor Jan Jörnmark, who talked about the global evolution of dense cities.

King’s College London has been awarded the Biotechnology and Biological Sciences Research Council’s (BBSRC) ‘Activating Impact’ prize in recognition of the College’s contribution to delivering real-world impact from bioscience research.

Cell2B’s lead product, ImmuneSafe, will be developed in collaboration with the the Portuguese Institute of Oncology

Technology, business and political leaders gathered at Imperial West to launch the London Node of a major European ICT innovation network this week.

The EU’s main climate innovation initiative Climate-KIC and regional research and innovation network ERRIN have signed a memorandum of understanding at the Committee of the Regions in Brussels today (19 March 2014), agreeing to develop joint activities and share information.